酒渣鼻
毛细血管扩张
等级间信度
医学
卡帕
组内相关
分级(工程)
内部评级可靠性
皮肤病科
分级比例尺
科恩卡帕
漆
皮肤镜检查
可靠性(半导体)
评定量表
外科
心理测量学
内科学
统计
置信区间
数学
几何学
涂层
痤疮
黑色素瘤
量子力学
癌症研究
临床心理学
化学
有机化学
功率(物理)
土木工程
工程类
物理
作者
Lynhda Nguyen,Nikolaus Seeber,Jens Malte Baron,Stefan Hammes,Syrus Karsai,Tanja Fischer,Laurence Imhof,Gerd Kautz,Sonja Sattler,Maximilian Deußing,Cathy Dierckxsens,Alexander Thiem,Zacharias Drosos,Stephan Grosse‐Buening,Nomun Ganjuur,Andreas Kampmann,J. May,Stefan W. Schneider,Martina Kerscher,Katharina Herberger
摘要
ABSTRACT Background Telangiectasia is a prominent feature of rosacea leading to a high demand for effective treatment. To ensure consistent clinical and scientific evaluations and assess treatment response accurately, standardized assessment tools are necessary for grading the severity of telangiectasia. However, no validated grading scales for this condition are currently available. Aim To develop and validate a photonumeric scale for assessing the severity of telangiectasia in rosacea patients. Methods The five‐point photonumeric Telangiectasia in Rosacea Severity Assessment (TRoSA) scale was developed for the severity of telangiectasia in rosacea. Sixteen experts participated in the validation process, evaluating 50 images of rosacea patients in two rounds. Interrater and intrarater reliability were analyzed using the intraclass correlation coefficient (ICC) and weighted kappa, respectively. Results Interrater reliability was found to be “almost perfect” in both validation rounds (Round 1: ICC 0.847; Round 2: ICC 0.828). The mean weighted kappa indicated “substantial” intrarater reliability between the two rounds with a weighted kappa of 0.719. A bubble plot of the two rounds illustrated a diagonal order, confirming the consistency of the intrarater agreement. Conclusions The TRoSA scale demonstrated high interrater and intrarater reliability indicating that it is a consistent and reproducible tool for grading the severity of telangiectasia in rosacea. This scale can standardize clinical assessments, assisting in diagnosis, treatment planning, and evaluation of therapeutic efficacy.
科研通智能强力驱动
Strongly Powered by AbleSci AI